Skip to main content
SpringerLink
Log in

Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine

  • Original Paper
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

Human urine contains several macromolecules which inhibit calcium oxalate crystallization. Uronic-acid-rich protein (UAP), a glycoprotein with a molecular weight of approximately 35 kDa, is one such inhibitor. Here we report the characterization of UAP extracted from rat urine using three chromatographic steps including diethylaminoethanol (DEAE)-Sephacel, Sephacryl S-300 and Mono Q column and compare it with human UAP. The molecular weight of rat UAP (UAPr) is similar to that of human UAP (UAPh), being approximately 35 kDa as estimated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Their amino acid compositions are identical, they contain a high percentage of aspartic and glutamic acids and they react positively in the carbazole reaction, suggesting that they contain uronic acid. The inhibitory activities of UAPh and UAPr were assayed on a calcium oxalate crystallization system in vitro using [45Ca]calcium chloride. Both exert a strong inhibition, suggesting that UAPr, like UAPh, plays an important role in preventing and reducing calcium oxalate crystallization in the urine. On Western blot analysis, both UAPh and UAPr immunoreact with inter-α-trypsin inhibitor (ITI) antibody. Nevertheless, using the Ouchterlony immunodiffusion technique, there was no precipitation line between ITI antibody and UAP. Therefore, we hypothesize that UAP is related to ITI and that they may have the same epitope but are not completely identical. We conclude that UAP belongs to the ITI superfamily of macromolecules which contribute to the regulation of the calcium oxalate crystallization process.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Atmani F, Lacour B, Drüeke T, Daudon M (1993) Isolation and purification of a new glycoprotein from human urine inhibiting calcium oxalate crystallization. Urol Res 21:61

    Google Scholar 

  2. Atmani F, Lacour B, Strecker G, Parvy P, Drüeke T, Daudon M (1993) Molecular characteristics of uronic-acid-rich protein, a strong inhibitor of calcium oxalate crystallization in vitro. Biochem Biophys Res Comm 191:1158

    Google Scholar 

  3. Atmani F, Lacour B, Jungers P, Drüeke T, Daudon M (1994) Reduced inhibitory activity of uronic-acid-rich protein (UAP) in the urine of stone formers. Urol Res 22:257

    Google Scholar 

  4. Bitter T, Muir HM (1962) A modified uronic acid carbazole reaction. Anal Biochem 4:330

    Google Scholar 

  5. Bowyer RC, Brockis JG, McCulloch RK (1979) Glycosaminoglycans as inhibitors of calcium oxalate crystal growth and aggreagation. Clin Chim Acta 95:23

    Google Scholar 

  6. Chawla RK, Lawson DH, Ahmed M, Travis J (1992) Cancer-related urinary proteinase inhibitor, EDC1: a new method for its isolation and evidence for multiple forms. J Cell Biochem 50:227

    Google Scholar 

  7. Chawla RK, Wadsworth AD, Rudman D (1978) Antitryptic property of cancer-related glycoprotein EDC1. Cancer Res 38:452

    Google Scholar 

  8. Hess B, Nakagawa Y, Coe FL (1989) Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 257:F99

    Google Scholar 

  9. Laroui S, Balduyck M, Mizon C, Selloum L, Mizon J (1988) Plasma proteins immunologically related to inter-α-trypsin inhibitor. Biochim Biophys Acta 953:263

    Google Scholar 

  10. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265

    Google Scholar 

  11. McKeehan WL, Sakagami Y, Hoshi H, McMeehan KA (1986) Two apparent human endothelial growth factors from human hepatoma cells are tumor-associated proteinase inhibitors. J Biol Chem 261:5378

    Google Scholar 

  12. Morrissey JH (1981) Silver stain for protein in polyacrylamide gels: a modified procedure with enhanced uniform sensitivity. Anal Biochem 117:307

    Google Scholar 

  13. Nakagawa Y, Abram V, Kezdy FJ, Kaiser ET, Coe FL (1983) Purificat on and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem 258:12594

    Google Scholar 

  14. Odum L, Hansen-Nord G, Byrjalsen I (1987) Human inter-α-trypsin inhibitor and immunologically related inhibitors investigated by quantitative immunoelectrophoresis. II. Pathological conditions. Clin Chim Acta 162:189

    Google Scholar 

  15. Ouchterlony O (1962) Diffusion-in-gel methods for immunological analysis. Prog Allergy 6:30

    Google Scholar 

  16. Potempa J, Kwon K, Chawla R, Travis J (1989) Inter-α-trypsin inhibitor. Inhibition spectrum of native and derived forms. J Biol Chem 164:15109

    Google Scholar 

  17. Reisinger P, Hochstrasser K, Albrecht GJ, Lempart K, Salier JP (1985) Human inter-α-trypsin inhibitor: localization of the kunitz-type domains in the N-terminal part of the molecule and their release by a trypsin-like proteinase. Biol Chem Hoppe-Seyler 366:479

    Google Scholar 

  18. Rouet P, Daveau M, Salier J (1992) Electrophoretic pattern of the inter-α-trypsin inhibitor family proteins in human serum, characterization by chain-specific antibodies. Biol Chem Hoppe-Seyler 373:1019

    Google Scholar 

  19. Shiraga H, Min W, Vandusen WJ, Clayman MD, Miner D, Terrell CH, Sherbotie JR, Foreman JW, Przysiecki C, Neilson EG, Hoyer JR (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 89:426

    Google Scholar 

  20. Sorensen S, Hansen K, Bak S, Justesen SJ (1990) An unidentified macromolecular inhibitory constituent of calcium oxalate crystal growth in human urine. Urol Res 8:373

    Google Scholar 

  21. Toki N, Sumi H (1982) Urinary trypsin inhibitor and urokinase activities in renal disease. Acta Haemat 67:109

    Google Scholar 

  22. Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitro-cellulose sheets: procedures and some application. Proc Natl Acad Sci USA 76:4350

    Google Scholar 

  23. Yoshida E, Sumi H, Maruyama M, Tsushima H, Matsuoka Y, Sugiki M, Mihara H (1989) Distribution of acid-stable trypsin inhibitor immunoreactivity in normal and malignant human tissues. Cancer 64:860

    Google Scholar 

  24. Yoshida E, Sumi H, Tsushima H, Maruyama M, Mihara H (1991) Distribution and localization of inter-α-trypsin inhibitor and its active component acid-stable proteinase inhibitor: comparative immunohistochemical study. Inflammation 15:71

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. College of Medicine, Department of Pathology and Laboratory Medicine, University of Florida, 32610, Gainesville, FL, USA

    F. Atmani & S. R. Khan

Authors
  1. F. Atmani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. R. Khan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atmani, F., Khan, S.R. Characterization of uronic-acid-rich inhibitor of calcium oxalate crystallization isolated from rat urine. Urol Res 23, 95–101 (1995). https://doi.org/10.1007/BF00307939

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00307939

Key words

Search

Navigation